1 Anderson, JW (2003) Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc 62, 135–142.
2 Jacobs, DR, Meyer, KA, Kushi, LH, et al. (1998) Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 68, 248–257.
3 Liu, SM, Stampfer, MJ, Hu, FB, et al. (1999) Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 70, 412–419.
4 Liu, SM, Manson, JE, Stampfer, MJ, et al. (2000) Whole grain consumption and risk of ischemic stroke in women – a prospective study. JAMA 284, 1534–1540.
5 McKeown, NM, Jacques, P & Mayer, J (2001) Whole grain intake and risk of ischemic stroke in women. Nutr Rev 59, 149–152.
6 Ajani, UA, Ford, ES & Mokdad, AH (2004) Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey Data. J Nutr 134, 1181–1185.
7 Pereira, MA, Jacobs, DR, Kushi, LH, et al. (1998) Whole grain consumption, body weight, fat distribution, and insulin in a bi-racial cohort of young adults: The CARDIA Study. Circulation 97, 18.
8 McKeown, NM, Meigs, JB, Liu, SM, et al. (2002) Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76, 390–398.
12 Truswell, AS (2002) Cereal grains and coronary heart disease. Eur J Clin Nutr 56, 1–14.
13 Pereira, MA, Jacobs, DR, Pins, JJ, et al. (2002) Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 75, 848–855.
14 Andersson, A, Tengblad, S, Karlstrom, B, et al. (2007) Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr 137, 1401–1407.
15 Behall, KM, Scholfield, DJ & Hallfrisch, J (2006) Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J Am Diet Assoc 106, 1445–1449.
16 Katcher, HI, Legro, RS, Kunselman, AR, et al. (2008) The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 87, 79–90.
18 Life Sciences Research Office (2008) Whole Grain Intake and Cardiovascular Disease and Whole Grain Intake and Diabetes: A Review. Bethesda, MD: Life Sciences Research Office.
19 Lang, R, Thane, CW, Bolton-Smith, C, et al. (2003) Consumption of whole-grain foods by British adults: findings from further analysis of two national dietary surveys. Public Health Nutr 6, 479–484.
20 Zanchetti, A (2003) 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21, 1011–1053.
21 Thane, CW, Jones, AR, Stephen, AM, et al. (2007) Comparative whole-grain intake of British adults in 1986–7 and 2000–1. Br J Nutr 97, 987–992.
22 Jebb, SA, Cole, TJ, Doman, D, et al. (2000) Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 83, 115–122.
23 Brady, LM, Gower, BA, Lovegrove, SS, et al. (2004) Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model. Int J Obes 28, 222–227.
24 Cicero, AFG, Nascetti, S, Lopez-Sabater, MC, et al. (2008) Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: The EUROLIVE study. J Am Coll Nutr 27, 314–320.
25 Madsen, MB, Jensen, AM & Schmidt, EB (2007) The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects. Clin Nutr 26, 792–798.
26 Jenkins, DJA, Kendall, CWC, Marchie, A, et al. (2005) Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81, 380–387.
28 Foster-Powell, K, Holt, SHA & Brand-Miller, JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76, 5–56.
29 Jenkins, DJA, Wesson, V, Wolever, TMS, et al. (1988) Wholemeal versus wholegrain breads – proportion of whole or cracked grain and the glycemic response. BMJ 297, 958–960.
30 Wesenberg, JC, Carter, K, Kadatz, D, et al. (2000) Evaluation of Dade-Behring, Sigma and Randox homogeneous HDL cholesterol assays on the Dade-Behring Dimension RxL. Clin Chem 46, A94–A94.
31 Nandeesha, H, Koner, BC, Dorairajan, LN, et al. (2006) Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta 370, 89–93.
32 Amsel, L, Cybulski, R & Wessel, B (2001) Performance of a revised triglycerides method on the Dade Behring Dimension® clinical chemistry system. Clin Chem 47, A57–A57.
33 Shimizu, S, Tani, Y, Yamada, H, et al. (1980) Enzymatic determination of serum-free fatty-acids – a colorimetric method. Anal Biochem 107, 193–198.
34 Savoca, R, Jaworek, B & Huber, AR (2006) New ‘plasma referenced’ POCT glucose monitoring systems – are they suitable for glucose monitoring and diagnosis of diabetes? Clin Chim Acta 372, 199–201.
35 Andersen, L, Dinesen, B, Jorgensen, PN, et al. (1993) Enzyme-immunoassay for intact human insulin in serum or plasma. Clin Chem 39, 578–582.
36 Katz, A, Nambi, SS, Mather, K, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402–2410.
37 Rabasa-Lhoret, R, Bastard, JP, Jan, V, et al. (2003) Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88, 4917–4923.
38 Register, TC, Burdon, KP, Lenchik, L, et al. (2004) Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem 50, 2185–2187.
39 Garton, KJ, Gough, PJ, Philalay, J, et al. (2003) Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-α-converting enzyme (ADAM 17). J Biol Chem 278, 37459–37464.
40 Ruchaud-Sparagano, MH, Drost, EM, Donnelly, SC, et al. (1998) Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol 28, 80–89.
41 Webber, D, Radcliffe, CM, Royle, L, et al. (2006) Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. FEBS J 273, 3024–3037.
42 Roberts, WL, Moulton, L, Law, TC, et al. (2001) Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47, 418–425.
43 Wehlin, L, Vedin, J, Vaage, J, et al. (2004) Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery. Eur J Cardiothorac Surg 25, 35–42.
44 Al-Barjas, HS, Ariens, R, Grant, P, et al. (2006) Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 57, 607–614.
45 Pannekoek, H, Veerman, H, Lambers, H, et al. (1986) Endothelial plasminogen-activator inhibitor (PAI) – a new member of the serpin gene family. EMBO J 5, 2539–2544.